Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 4.2M | $15M | 100% | Sep 2025 |
|
| OrbiMed Advisors | 3.1M | $2.1M | 0% | Dec 2025 |
|
| TCG Crossover Management | 2.7M | $1.8M | 0% | Dec 2025 |
|
| Vanguard Group | 1.8M | $1.2M | 8% | Dec 2025 |
|
| Susquehanna International | 825k | $546k | 149% | Dec 2025 |
|
| ADAR1 Capital Management | 744k | $492k | 558% | Dec 2025 |
|
| Stempoint Capital | 617k | $142k | -75% | Dec 2025 |
|
| Jane Street | 607k | $402k | 91% | Dec 2025 |
|
| Ikarian Capital | 519k | $344k | -16% | Dec 2025 |
|
| Citadel Advisors | 464k | $1.6M | 351% | Sep 2025 |
|
| BlackRock | 423k | $280k | 0% | Dec 2025 |
|
| Geode Capital Management | 353k | $234k | 18% | Dec 2025 |
|
| Luminus Management | 350k | $232k | 100% | Dec 2025 |
|
| Two Sigma Investments | 289k | $1.0M | 224% | Sep 2025 |
|
| Jpmorgan Chase & Co | 272k | $965k | 100% | Sep 2025 |
|
| AdvisorShares Investments | 250k | $166k | 21% | Dec 2025 |
|
| Diadema Partners | 207k | $137k | -54% | Dec 2025 |
|
| Renaissance Technologies | 161k | $106k | -62% | Dec 2025 |
|
| Two Sigma Advisers | 157k | $558k | 508% | Sep 2025 |
|
| Dimensional Fund Advisors | 152k | $101k | 123% | Dec 2025 |
|
| Boothbay Fund Management | 135k | $89k | -32% | Dec 2025 |
|
| State Street Corporation | 121k | $80k | 25% | Dec 2025 |
|
| Group One Trading | 106k | $70k | 267% | Dec 2025 |
|
| OMERS Administration Corporation | 103k | $68k | 100% | Dec 2025 |
|
| Caption Management | 78k | $52k | 100% | Dec 2025 |
|
| Northern Trust | 73k | $48k | 51% | Dec 2025 |
|
| Seven Fleet Capital Management | 63k | $42k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 60k | $40k | 100% | Dec 2025 |
|
| Occudo Quantitative Strategies | 59k | $39k | 38% | Dec 2025 |
|
| UBS Group | 52k | $34k | 103% | Dec 2025 |
|
| American Century Companies | 49k | $32k | 19% | Dec 2025 |
|
| Cubist Systematic Strategies | 44k | $156k | 100% | Sep 2025 |
|
| Virtu Financial | 38k | $25k | 100% | Dec 2025 |
|
| Hrt Financial | 38k | $24k | 100% | Dec 2025 |
|
| Engineers Gate Manager | 31k | $20k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 27k | $18k | -65% | Dec 2025 |
|
| Kestra Advisory Services | 26k | $17k | 30% | Dec 2025 |
|
| Charles Schwab Investment Management | 23k | $15k | 0% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 22k | $14k | 100% | Dec 2025 |
|
| Millennium Management | 21k | $73k | 100% | Sep 2025 |
|
| HighTower Advisors | 21k | $14k | -1% | Dec 2025 |
|
| Lighthouse Investment Partners | 21k | $14k | 100% | Dec 2025 |
|
| None | 20k | $13k | 100% | Dec 2025 |
|
| Marshall Wace | 20k | $13k | 100% | Dec 2025 |
|
| Truvestments Capital | 17k | $11k | 96% | Dec 2025 |
|
| Intl Fcstone | 13k | $8.8k | 100% | Dec 2025 |
|
| William Blair $ Company | 13k | $45k | -85% | Sep 2025 |
|
| DRW Holdings | 10k | $6.6k | 100% | Dec 2025 |
|
| Tower Research Capital | 8.6k | $5.7k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 5.3k | $3.5k | 29% | Dec 2025 |
|
| Performa | 1.0k | $662.000000 | 0% | Dec 2025 |
|
| CWM | 582.00 | $0 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 526.00 | $349.001000 | 0% | Dec 2025 |
|
| SBI Securities | 288.00 | $191.001600 | -1% | Dec 2025 |
|
| Jones Financial Companies, L.L | 114.00 | $75.000600 | 0% | Dec 2025 |
|
| Fairman Group | 29.00 | $19.000800 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 13.00 | $8.999900 | -77% | Dec 2025 |
|
Who sold out of Vistagen Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Sep 2025 | 2.0M | $7.0M |
| Commodore Capital | Sep 2025 | 1.6M | $5.6M |
| Soleus Capital Management | Sep 2025 | 550k | $2.0M |
| Almitas Capital | Sep 2025 | 261k | $928k |
| BML Capital Management | Sep 2025 | 150k | $533k |
| XTX Topco | Sep 2025 | 70k | $248k |
| Walleye Trading Advisors | Sep 2025 | 68k | $241k |
| Goldman Sachs Group | Sep 2025 | 60k | $214k |
| GSA Capital Partners | Sep 2025 | 32k | $112k |
| FNY Investment Advisers | Sep 2025 | 6.0k | $21k |
| Royal Bank of Canada | Jun 2025 | 3.3k | $7.0k |